Results 221 to 230 of about 449,883 (300)

SGLT2 Inhibitors and Cardiovascular Outcomes in Patients With Fabry Disease: Observations From a Federated Research Network

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background and Aim Fabry disease (FD) is frequently complicated by renal impairment and cardiovascular events; however, evidence on sodium–glucose cotransporter‐2 inhibitors (SGLT2i) in this population is scarce. Accordingly, we assessed the association between SGLT2i exposure and cardiovascular outcomes in adults with FD. Methods We conducted
Leandra Serio, Michele Rossi, Amir Askarinejad, Enrico Tartaglia, Tommaso Bucci, Enrica Marrone, Dinesh K. Kalra, Claudio Ferri, Gregory Y. H. Lip   +8 more
wiley   +1 more source

Connexin43 Deficiency Leads to Ventricular Arrhythmias by Reprogramming Proline Metabolism. [PDF]

Adv Sci (Weinh)
Ying H, Fan H, Wang Y, Jiang R, Cai D, Cheng H, Wang H, Jiang C, Liang P.   +8 more
europepmc   +1 more source

Chd4 and ThPOK cooperate to preserve structural and electrophysiological integrity of the adult heart through Sprr1a repression

The FEBS Journal, EarlyView.
Chd4/NuRD and ThPOK cooperate to maintain transcriptional repression and nuclear organization in adult cardiomyocytes. Chd4 loss reduces miR‐150‐5p, relieving repression of Sprr1a, while ThPOK loss further enhances Sprr1a activation, possibly through altered chromatin–lamina interactions.
Fadoua El Abdellaoui‐Soussi, Apolonia Novillo, Rocío Brea, Marta Ysbert, Lorena Cussó, Gonzalo Pizarro‐Sánchez, Manuel Desco, Iván Hernández, Ángel Luis Armesilla, Ignacio Pérez de Castro, Alicia R. Folgueras, Juan Miguel Redondo, Pablo Gómez‐del Arco   +12 more
wiley   +1 more source

Rare but relevant: Ibogaine and cardiovascular complications-prolonged QT interval and ventricular arrhythmias. [PDF]

Addiction
Brunt TM.
europepmc   +1 more source

Andersen-Tawil syndrome with high-burden ventricular arrhythmias: a case report. [PDF]

BMC Cardiovasc Disord
Feng R, Gao J, Guo Y, Zhang Z, Fu X, Wang R, Guo M.   +6 more
europepmc   +1 more source

Multidisciplinary Approach to Ventricular Arrhythmias in the CICU: Integrating Mechanical Circulatory Support, Ablation, and Emerging Therapies. [PDF]

J Clin Med
Mauriello A, Correra A, Maratea AC, Cetoretta V, Giallauria F, Esposito G, Desiderio A, Sabatella F, Marrazzo G, Liccardo B, Russo V, Trambaiolo P, D'Andrea A.   +12 more
europepmc   +1 more source

ECG and Anatomical Features in Patients of Left Coronary Cusp Ventricular Arrhythmias With R Wave in Lead I. [PDF]

J Arrhythm
Hara S, Hachiya H, Miwa N, Tsumagari Y, Sato Y, Nakata T, Ishizawa T, Setoguchi M, Shimosato H, Kusa S, Sasano T.   +10 more
europepmc   +1 more source

Extracellular-cAMP suppresses pulmonary arterial hypertension-induced ventricular arrhythmias. [PDF]

J Mol Cell Cardiol
Cacheux M, Strauss B, Parajuli S, Halouani A, Katz MG, Imani S, Antar S, Bedoya N, Hadri L, Akar FG, Sassi Y.   +10 more
europepmc   +1 more source

Extravascular Implantable Cardioverter-Defibrillator Therapy for Malignant Ventricular Arrhythmias in a Child with Congenital Long QT Syndrome: A Case Report. [PDF]

J Cardiovasc Dev Dis
Sun X, Wang H, Wang Y, Gong F, Ying L, Wang W.   +5 more
europepmc   +1 more source